| The Fanconi Anemia Pathway in Cancer |
54 |
| The Hallmarks of Ferroptosis |
47 |
| Homology-Directed Repair and the Role of BRCA BRCA and Related Proteins in Genome Integrity and Cancer |
30 |
| Cancer Immunotherapy: Beyond Checkpoint Blockade |
29 |
| Natural Killer Cells in Cancer Immunotherapy |
21 |
| Emerging Topics on Disseminated Cancer Cell Dormancy and the Paradigm of Metastasis |
15 |
| Lineage Plasticity in Cancer Progression and Treatment |
14 |
| Deciphering Human Tumor Biology by Single-Cell Expression Profiling |
12 |
| MiT/TFE Family of Transcription Factors, Lysosomes, and Cancer |
12 |
| Roles of the cGAS-STING Pathway in Cancer Immunosurveillance and Immunotherapy |
12 |
| Proteolysis-Targeting Chimeras: Harnessing the Ubiquitin-Proteasome System to Induce Degradation of Specific Target Proteins |
11 |
| Resistance to PARP Inhibitors: Lessons from Preclinical Models of BRCA-Associated Cancer |
11 |
| NAD(+) Metabolism in Aging and Cancer |
11 |
| Aberrant RNA Splicing in Cancer |
11 |
| Targeting Therapies for the p53 Protein in Cancer Treatments |
10 |
| PARP Trapping Beyond Homologous Recombination and Platinum Sensitivity in Cancers |
10 |
| Extracellular Vesicles and Cancer: Caveat Lector |
10 |
| Targeting KRAS Directly |
9 |
| HSP90: Enabler of Cancer Adaptation |
9 |
| Oncolytic Herpes Simplex Viruses as a Paradigm for the Treatment of Cancer |
8 |
| Harnessing Protease Activity to Improve Cancer Care |
8 |
| Organoid Models for Cancer Research |
8 |
| SWI/SNF (BAF) Complexes: Guardians of the Epigenome |
7 |
| Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer |
5 |
| Regulation and Dysregulation of Chromosome Structure in Cancer |
5 |
| The Impact of the Gut Microbiome on Colorectal Cancer |
5 |
| Aiding and Abetting: How the Tumor Microenvironment Protects Cancer from Chemotherapy |
5 |
| Academic Discovery of Anticancer Drugs: Historic and Future Perspectives |
5 |
| Modeling Cancer in the CRISPR Era |
4 |
| The Power Behind the Throne: Senescence and the Hallmarks of Cancer |
4 |
| Mechanisms of Tumor Cell-Intrinsic Immune Evasion |
4 |
| Dietary Fat and Sugar in Promoting Cancer Development and Progression |
4 |
| Taming the Heterogeneity of Aggressive Lymphomas for Precision Therapy |
3 |
| Nutrient Sensing in Cancer |
3 |
| Circadian Clock's Cancer Connections |
3 |
| Hormone-Targeted Therapy and Resistance |
2 |
| Histone Mutations in Cancer |
2 |
| Insights from Large-Scale Cancer Genome Sequencing |
2 |
| The von Hippel-Lindau Tumor Suppressor Protein |
1 |
| Biology and Therapy of Dominant Fusion Oncoproteins Involving Transcription Factor and Chromatin Regulators in Sarcomas |
1 |
| A Joint Odyssey into Cancer Genetics |
1 |
| Targeting Cancer at the Intersection of Signaling and Epigenetics |
0 |
| Functional Genomics for Cancer Research: Applications In Vivo and In Vitro |
0 |
| Circulating Tumor DNA: Clinical Monitoring and Early Detection |
0 |
| Prophylactic Vaccines for Nonviral Cancers |
0 |
| Pastimes in Cancer Biology |
0 |
